Skip to search.
 STI Up 0.37%

Biogen Inc. (BIIB)

-NasdaqGS
428.93 Down 2.70(0.63%) 04:00 SGT
|After Hours : 428.30 Down 0.63 (0.15%) 06:48 SGT
Add to Portfolio
Prev Close:431.63
Open:427.80
Bid:427.60 x 100
Ask:430.95 x 200
1y Target Est:474.98
Beta:0.62
Earnings Date:21 Apr - 27 Apr (Est.)
Day's Range:420.41 - 432.88
52wk Range:272.02 - 480.18
Volume:3,354,290
Avg Vol (3m):1,863,840
Market Cap:100.63B
P/E (ttm):34.68
EPS (ttm):12.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 0.63%100.63B
PFEDown 0.41%209.36B

Key Statistics

Forward P/E (1 yr):21.58
P/S (ttm):10.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :17.03
Quarterly EPS Est (Mar-15) :3.93
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.41

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback